Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials

The present study was an updated meta-analysis that aimed to confirm the efficacy and safety of dutasteride (0.5 mg) and finasteride (5 mg) in treating males with benign prostatic hyperplasia (BPH) over a treatment period of at least 6 months. Randomized controlled trials were retrieved using the ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhongbao, Cui, Yuanshan, Wu, Jitao, Jin, Hairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388259/
https://www.ncbi.nlm.nih.gov/pubmed/32742388
http://dx.doi.org/10.3892/etm.2020.8851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388259/
https://www.ncbi.nlm.nih.gov/pubmed/32742388
http://dx.doi.org/10.3892/etm.2020.8851

Ejemplares similares